WILLARD CUPP: Open Payments
NPI 1265021406 · ELKHART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 13 payments from 7 companies in 2025. Trend: 2023 $366 · 2024 $164 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $62 |
| ABBVIE INC. | 3 | $61 |
| Neurocrine BioSciences, Inc. | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Alkermes, Inc. | 1 | $18 |
Products named: FANAPT, VRAYLAR, INGREZZA, CAPLYTA, REXULTI, SPRAVATO, ARISTADA.
Industry payments across IN — which companies pay providers there.
